|
Real-time
Euronext Paris
21:44:40 12/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 87.60 EUR | -0.45% |
|
-1.59% | +40.42% |
| 11-09 | Fitch Affirms Eurofins Scientific on Strong Business Risk Profile | MT |
| 10-26 | Eurofins Scientific, Heading for a Sixth Consecutive Gain |  |
Company Valuation: Eurofins Scientific SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 20,893 | 12,900 | 11,336 | 9,273 | 11,036 | 15,030 | - | - |
| Change | - | -38.26% | -12.13% | -18.2% | 19.02% | 36.18% | - | - |
| Enterprise Value (EV) 1 | 23,132 | 15,739 | 14,041 | 12,269 | 14,677 | 18,458 | 18,108 | 17,755 |
| Change | - | -31.96% | -10.79% | -12.62% | 19.63% | 25.76% | -1.9% | -1.95% |
| P/E | 27.8x | 22.2x | 45.4x | 26.9x | 28x | 28.7x | 22.9x | 19.3x |
| PBR | 4.49x | 2.7x | 2.24x | 1.73x | 2.56x | 3.24x | 2.93x | 2.69x |
| PEG | - | -1x | -0.8x | 0.7x | 1.3x | 0.8x | 0.9x | 1.1x |
| Capitalization / Revenue | 3.11x | 1.92x | 1.74x | 1.33x | 1.51x | 1.99x | 1.87x | 1.76x |
| EV / Revenue | 3.44x | 2.34x | 2.16x | 1.77x | 2.01x | 2.44x | 2.26x | 2.08x |
| EV / EBITDA | 12.2x | 10.4x | 10.3x | 7.91x | 8.94x | 10.4x | 9.38x | 8.5x |
| EV / EBIT | 15.7x | 15.2x | 16.7x | 12.1x | 13.6x | 16.1x | 14.2x | 12.7x |
| EV / FCF | 22.8x | 23.2x | 29.6x | 15.3x | 16.7x | 22.4x | 19.8x | 17.7x |
| FCF Yield | 4.39% | 4.3% | 3.38% | 6.53% | 5.97% | 4.46% | 5.06% | 5.64% |
| Dividend per Share 2 | 1 | 1 | 0.5 | 0.5 | 0.72 | 0.8002 | 0.9166 | 0.9653 |
| Rate of return | 0.92% | 1.49% | 0.85% | 1.01% | 1.15% | 0.91% | 1.04% | 1.1% |
| EPS 2 | 3.91 | 3.02 | 1.3 | 1.83 | 2.23 | 3.061 | 3.85 | 4.55 |
| Distribution rate | 25.6% | 33.1% | 38.5% | 27.3% | 32.3% | 26.1% | 23.8% | 21.2% |
| Net sales 1 | 6,718 | 6,712 | 6,515 | 6,951 | 7,296 | 7,568 | 8,022 | 8,543 |
| EBITDA 1 | 1,902 | 1,513 | 1,364 | 1,552 | 1,641 | 1,776 | 1,930 | 2,088 |
| EBIT 1 | 1,473 | 1,037 | 842 | 1,017 | 1,079 | 1,148 | 1,274 | 1,403 |
| Net income 1 | 783 | 606 | 310 | 406 | 475 | 547 | 675.3 | 783.7 |
| Net Debt 1 | 2,239 | 2,839 | 2,705 | 2,996 | 3,641 | 3,428 | 3,078 | 2,725 |
| Reference price 2 | 108.80 | 67.06 | 58.98 | 49.31 | 62.40 | 88.00 | 88.00 | 88.00 |
| Nbr of stocks (in thousands) | 192,035 | 192,365 | 192,194 | 188,049 | 176,864 | 170,792 | - | - |
| Announcement Date | 22/2/22 | 1/3/23 | 27/2/24 | 30/1/25 | 29/1/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28.75x | 2.44x | 10.39x | 0.91% | 16.68B | |
| 17.64x | 6.77x | 12.98x | 1.69% | 67.53B | |
| 32.85x | 8.79x | 29.04x | 0.07% | 60.74B | |
| 38.46x | 6.84x | 20.46x | 0.85% | 55.66B | |
| 46.76x | 6.33x | 30.27x | -.--% | 47.97B | |
| 35.83x | 3.38x | 14.58x | -.--% | 45.24B | |
| -21.57x | 57.33x | -23.69x | -.--% | 39.08B | |
| 35.06x | 8.67x | 22.58x | 0.37% | 35.34B | |
| 41.53x | 8.15x | 27.06x | -.--% | 33.45B | |
| -73.68x | 13.96x | -75.03x | -.--% | 26.49B | |
| Average | 18.16x | 12.26x | 6.87x | 0.39% | 43B | |
| Weighted average by Cap. | 22.19x | 11.81x | 11.34x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ERF Stock
- Valuation Eurofins Scientific SE
Select your edition
All financial news and data tailored to specific country editions
